Boy in suit smiling
pipeline2.png
registry2.png
rideataxia2.png
advocacy2.png
energyball2.png
grassroots2.png

Featured FARA News and Blogs

Reata Pharmaceuticals Announces
FDA Approval of SKYCLARYS™ (Omaveloxolone)

View the recently updated
Clinical Management Guidelines for Friedreich Ataxia

Available Now! FARA’s Annual Donor Impact Report

Register for the 5th United Against Ataxia Hill Day

Clinical Trials now Enrolling Volunteers Needed!

Activities & Events